Synthesis, characterization and biological evaluation of some 16E-arylidene androstane derivatives as potential anticancer agentsHAO GUO; HAOTIAN WU; XIANMING HU et al.Steroids. 2011, Vol 76, Num 7, pp 709-723, issn 0039-128X, 15 p.Article

Synthesis and antitumor activity of new D-seco and D-homo androstane derivativesDJURENDIC, Evgenija A; ZAVIS, Marina P; SAKAC, Marija N et al.Steroids. 2009, Vol 74, Num 12, pp 983-988, issn 0039-128X, 6 p.Article

Synthesis and cytotoxicity of 17E-(2-aryl-2-oxo-1-ethylidene)-5α-androstane derivativesYAN LI; JIE HUANG; JINLIANG LIU et al.Steroids. 2011, Vol 76, Num 14, pp 1615-1620, issn 0039-128X, 6 p.Article

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane StudyBLISS, Judith M; KILBURN, Lucy S; DE VELDE, Cornelis J. H. Van et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 709-717, issn 0732-183X, 9 p.Article

Detection of new urinary exemestane metabolites by gas chromatography coupled to mass spectrometryALBUQUERQUE CAVALCANTI, Gustavo De; CARIUS GARRIDO, Bruno; DIAS LEAL, Felipe et al.Steroids. 2011, Vol 76, Num 10-11, pp 1010-1015, issn 0039-128X, 6 p.Article

Severe prolonged cholestatic hepatitis caused by exemestaneTING BAO; FETTING, John; MUMFORD, Laura et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 789-791, issn 0167-6806, 3 p.Article

17β-Nitro-5α-androstan-3α-ol and its 3β-methyl derivative: Neurosteroid analogs with potent anticonvulsant and anxiolytic activitiesRUNYON, Scott P; ORR, Matthew; NAVARRO, Hernan A et al.European journal of pharmacology. 2009, Vol 617, Num 1-3, pp 68-73, issn 0014-2999, 6 p.Article

Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometryDE ALBUQUERQUE CAVALCANTI, Gustavo; CARIUS GARRIDO, Bruno; DIAS LEAL, Felipe et al.Journal of steroid biochemistry and molecular biology. 2011, Vol 127, Num 3-5, pp 248-254, issn 0960-0760, 7 p.Article

Exémestane et hormonthérapies adjuvantes : perspectivesLUPORSI, Elisabeth.La Lettre du cancérologue (Boulogne). 2008, Num DEC, pp 4-6, issn 1165-113X, 3 p., NSArticle

Synthesis of exemestane labelled with ¹³CFONTANA, Erminia; PIGNATTI, Alberto; GIRIBONE, Danilo et al.Steroids. 2008, Vol 73, Num 7, pp 760-764, issn 0039-128X, 5 p.Article

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast CancerPAGANI, Olivia; REGAN, Meredith M; CIRUELOS, Eva et al.The New England journal of medicine. 2014, Vol 371, Num 2, pp 107-118, issn 0028-4793, 12 p.Article

A facile 'click' approach to novel 15β-triazolyl-5α-androstane derivatives, and an evaluation of their antiproliferative activities in vitroKADAR, Zalán; MOLNAR, Judit; SCHNEIDER, Gyula et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 4, pp 1396-1402, issn 0968-0896, 7 p.Article

Compliance, Analgesic Use and Side-effect Protection within a German Cohort of the TEAM TrialBOSSART, Michaela; BECKER, Meike; HADJI, Peyman et al.Anticancer research. 2012, Vol 32, Num 9, pp 3933-3938, issn 0250-7005, 6 p.Article

Binding features of steroidal and nonsteroidal inhibitorsYANYAN HONG; RASHID, Rumana; SHIUAN CHEN et al.Steroids. 2011, Vol 76, Num 8, pp 802-806, issn 0039-128X, 5 p.Conference Paper

Characterization of the weak estrogen receptor α agonistic activity of exemestaneMASRI, Selma; KI LUI; PHUNG, Sheryl et al.Breast cancer research and treatment. 2009, Vol 116, Num 3, pp 461-470, issn 0167-6806, 10 p.Article

Novel and efficient synthesis and antifungal evaluation of 2,3-functionalized cholestane and androstane derivativesJURSIC, Branko S; SUNIL KUMAR UPADHYAY; CREECH, Clinton C et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 24, pp 7372-7375, issn 0960-894X, 4 p.Article

Bioequivalence of exemestane in post-menopausal femalesGROENEWOUD, Gerhard; NELL, Andre; POTGIETER, Linda et al.Arzneimittel-Forschung. 2010, Vol 60, Num 2, pp 96-100, issn 0004-4172, 5 p.Article

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2PICCART, M; HORTOBAGYI, G. N; BURRIS, H. A et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2357-2362, issn 0923-7534, 6 p.Article

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor―positive metastatic breast cancerESTEVA, Francisco J; MOULDER, Stacy L; GONZALEZ-ANGULO, Ana M et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 1, pp 63-72, issn 0344-5704, 10 p.Article

Poly(D, L-lactide-co-glycolide)/montmorillonite nanoparticles for improved oral delivery of exemestaneZHEN LI; KEXIN LIU; PENGYUAN SUN et al.Journal of microencapsulation. 2013, Vol 30, Num 5, pp 432-440, issn 0265-2048, 9 p.Article

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisationFALLOWFIELD, L. J; KILBURN, L. S; LANGRIDGE, C et al.British journal of cancer. 2012, Vol 106, Num 6, pp 1062-1067, issn 0007-0920, 6 p.Article

Macrocyclic Molecular Rotors with Bridged Steroidal FrameworksCZAJKOWSKA-SZCZYKOWSKA, Dorota; RODRIGUEZ-MOLINA, Braulio; MAGANA-VERGARA, Nancy E et al.Journal of organic chemistry. 2012, Vol 77, Num 22, pp 9970-9978, issn 0022-3263, 9 p.Article

Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective: A Systematic Review of the LiteratureYOUNUS, Muhammad; KISSNER, Michelle; REICH, Lester et al.Drug safety. 2011, Vol 34, Num 12, pp 1125-1149, issn 0114-5916, 25 p.Article

Aromatase inhibition in male breast cancer patients: biological and clinical implicationsDOYEN, J; ITALIANO, A; LARGILLIER, R et al.Annals of oncology. 2010, Vol 21, Num 6, pp 1243-1245, issn 0923-7534, 3 p.Article

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trialsMARKOPOULOS, Christos J.Cancer metastasis reviews. 2010, Vol 29, Num 4, pp 581-594, issn 0167-7659, 14 p.Article